Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 23, 2023 - Issue 8: Biosimilars
Submit an article Journal homepage
206
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Pharmacokinetics, pharmacodynamics, safety and immunogenicity of recombinant, fully human anti-RANKL monoclonal antibody (MW031) versus denosumab in Chinese healthy subjects: a single-center, randomized, double-blind, single-dose, parallel-controlled trial

Yinhan Guoa Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, Jiangsu, ChinaView further author information
,
Tingting Guob Phase I Center, Peking University (PKU) Care, Luzhong Hospital, Zibo, Shandong, ChinaView further author information
,
Yujing Dib Phase I Center, Peking University (PKU) Care, Luzhong Hospital, Zibo, Shandong, ChinaView further author information
,
Wenyu Xua Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, Jiangsu, ChinaView further author information
,
Zhitian Hua Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, Jiangsu, ChinaView further author information
,
Yanfeng Xiaoa Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, Jiangsu, ChinaView further author information
,
Heze Yua Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, Jiangsu, ChinaORCID Iconhttps://orcid.org/0000-0002-6170-8622View further author information
ORCID Icon &
Jie Houb Phase I Center, Peking University (PKU) Care, Luzhong Hospital, Zibo, Shandong, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 705-715 | Received 22 Sep 2022, Accepted 06 Feb 2023, Published online: 09 Mar 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.